Unternehmen Advanced Proteome Therapeutics Corp. Other OTC
Aktien
CA0076281009
Holdinggesellschaften
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16.04.18 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10.03.09 |
Martin Woodward
BRD | Director/Board Member | 56 | 20.12.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20.12.18 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21.11.22 |
Paul Woodward
CEO | Chief Executive Officer | 63 | 16.04.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 41 127 080 | 36 950 363 ( 89,84 %) | 0 | 89,84 % |
Unternehmenskontakt
Advanced Proteome Therapeutics Corp.
8337 Eastlake Drive Suite 104
V5A 4W2, Burnaby
+(604) 690-3797
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+180.51% | 8.67 Mrd. | |
+2.29% | 983 Mio. | |
+41.91% | 883 Mio. | |
+26.17% | 825 Mio. | |
+1.92% | 665 Mio. | |
+9.52% | 664 Mio. | |
-.--% | 600 Mio. | |
+9.17% | 530 Mio. | |
-.--% | 500 Mio. |